Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DARE

Dare Bioscience (DARE)

Dare Bioscience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DARE
DateTimeSourceHeadlineSymbolCompany
01/07/20214:06PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DAREDare Bioscience Inc
01/05/20214:13PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:DAREDare Bioscience Inc
01/05/20218:00AMGlobeNewswire Inc.Daré Bioscience to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual ConferenceNASDAQ:DAREDare Bioscience Inc
12/23/20204:04PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:DAREDare Bioscience Inc
12/09/20204:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
12/07/20208:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
12/07/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with ...NASDAQ:DAREDare Bioscience Inc
11/18/20204:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
11/12/20204:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DAREDare Bioscience Inc
11/12/20208:00AMGlobeNewswire Inc.Daré Bioscience Reports Third Quarter 2020 Financial Results and Provides Company UpdateNASDAQ:DAREDare Bioscience Inc
11/05/20208:00AMGlobeNewswire Inc.Daré Bioscience to Host Third Quarter 2020 Financial Results and Company Update Conference Call and Webcast on November 12, ...NASDAQ:DAREDare Bioscience Inc
10/07/20208:00AMGlobeNewswire Inc.Daré Bioscience to Present at the 2020 BIO Investor Forum DigitalNASDAQ:DAREDare Bioscience Inc
10/06/20204:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
09/21/20208:00AMGlobeNewswire Inc.Daré Bioscience Receives $0.9 million Under the Current Grant Supplement Award for Continued Development of its User-Control...NASDAQ:DAREDare Bioscience Inc
09/11/20204:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DAREDare Bioscience Inc
09/09/20204:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
09/01/20208:04AMGlobeNewswire Inc.Daré Bioscience and Avomeen Form Strategic Partnership to Accelerate the Development of Daré’s Novel Pipeline of Women’...NASDAQ:DAREDare Bioscience Inc
08/20/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Publication of DARE-BV1 Proof of Concept Study for the Treatment of Bacterial VaginosisNASDAQ:DAREDare Bioscience Inc
08/19/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National ...NASDAQ:DAREDare Bioscience Inc
08/12/20204:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DAREDare Bioscience Inc
08/12/20208:00AMGlobeNewswire Inc.Daré Bioscience Reports Second Quarter 2020 Financial Results and Provides Company UpdateNASDAQ:DAREDare Bioscience Inc
08/06/20208:00AMGlobeNewswire Inc.Daré Bioscience CEO to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual ConferenceNASDAQ:DAREDare Bioscience Inc
08/05/20208:00AMGlobeNewswire Inc.Daré Bioscience to Host Second Quarter 2020 Financial Results and Company Update Conference Call and Webcast on August 12, 2...NASDAQ:DAREDare Bioscience Inc
07/27/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Initiation of Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver N...NASDAQ:DAREDare Bioscience Inc
07/15/20208:44AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DAREDare Bioscience Inc
06/26/20204:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DAREDare Bioscience Inc
06/24/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Publication of a Peer-Reviewed Journal Article Supporting the Use of the Postcoital Test Study as ...NASDAQ:DAREDare Bioscience Inc
06/17/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial VaginosisNASDAQ:DAREDare Bioscience Inc
06/15/20208:00AMGlobeNewswire Inc.Daré Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User...NASDAQ:DAREDare Bioscience Inc
06/09/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DAREDare Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:DARE